Selected research
Industry Research
Fexofenadine Hydrochloride Tablets Industry Research Report 2026
Market perspective
The global Fexofenadine Hydrochloride Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Fexofenadine Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Fexofenadine Hydrochloride Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Fexofenadine Hydrochloride Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Fexofenadine Hydrochloride Tablets include OPELLA HEALTHCARE FRANCE SAS, Sandoz, Sanofi, Lunan Pharmaceutical Group, Viatris, Teva Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Fexofenadine Hydrochloride Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Fexofenadine Hydrochloride Tablets Market by Company
OPELLA HEALTHCARE FRANCE SAS
Sandoz
Sanofi
Lunan Pharmaceutical Group
Viatris
Teva Pharmaceuticals
Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries
Dr. Reddy's Laboratories
CSPC Pharmaceutical Group
Fexofenadine Hydrochloride Tablets Segment by Type
120mg
180mg
60mg
Fexofenadine Hydrochloride Tablets Segment by Application
Clinic
Hospital
Others
Fexofenadine Hydrochloride Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fexofenadine Hydrochloride Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fexofenadine Hydrochloride Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fexofenadine Hydrochloride Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Fexofenadine Hydrochloride Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Fexofenadine Hydrochloride Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Fexofenadine Hydrochloride Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 120mg
- 180mg
- 60mg
Applications
- Clinic
- Hospital
- Others
Companies covered
- OPELLA HEALTHCARE FRANCE SAS
- Sandoz
- Sanofi
- Lunan Pharmaceutical Group
- Viatris
- Teva Pharmaceuticals
- Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries
- Dr. Reddy's Laboratories
- CSPC Pharmaceutical Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Fexofenadine Hydrochloride Tablets Market Size (2021-2032)
- 2.2.2 Global Fexofenadine Hydrochloride Tablets Sales (2021-2032)
- 2.2.3 Global Fexofenadine Hydrochloride Tablets Market Average Price (2021-2032)
- 2.3 Fexofenadine Hydrochloride Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 120mg
- 2.3.3 180mg
- 2.3.4 60mg
- 2.4 Fexofenadine Hydrochloride Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinic
- 2.4.3 Hospital
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Fexofenadine Hydrochloride Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Fexofenadine Hydrochloride Tablets Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Fexofenadine Hydrochloride Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Fexofenadine Hydrochloride Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Fexofenadine Hydrochloride Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Fexofenadine Hydrochloride Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Fexofenadine Hydrochloride Tablets, Product Type & Application
- 3.8 Global Manufacturers of Fexofenadine Hydrochloride Tablets, Established Date
- 3.9 Global Fexofenadine Hydrochloride Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 OPELLA HEALTHCARE FRANCE SAS
- 4.1.1 OPELLA HEALTHCARE FRANCE SAS Company Information
- 4.1.2 OPELLA HEALTHCARE FRANCE SAS Business Overview
- 4.1.3 OPELLA HEALTHCARE FRANCE SAS Fexofenadine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 OPELLA HEALTHCARE FRANCE SAS Fexofenadine Hydrochloride Tablets Product Portfolio
- 4.1.5 OPELLA HEALTHCARE FRANCE SAS Recent Developments
- 4.2 Sandoz
- 4.2.1 Sandoz Company Information
- 4.2.2 Sandoz Business Overview
- 4.2.3 Sandoz Fexofenadine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sandoz Fexofenadine Hydrochloride Tablets Product Portfolio
- 4.2.5 Sandoz Recent Developments
- 4.3 Sanofi
- 4.3.1 Sanofi Company Information
- 4.3.2 Sanofi Business Overview
- 4.3.3 Sanofi Fexofenadine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sanofi Fexofenadine Hydrochloride Tablets Product Portfolio
- 4.3.5 Sanofi Recent Developments
- 4.4 Lunan Pharmaceutical Group
- 4.4.1 Lunan Pharmaceutical Group Company Information
- 4.4.2 Lunan Pharmaceutical Group Business Overview
- 4.4.3 Lunan Pharmaceutical Group Fexofenadine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Lunan Pharmaceutical Group Fexofenadine Hydrochloride Tablets Product Portfolio
- 4.4.5 Lunan Pharmaceutical Group Recent Developments
- 4.5 Viatris
- 4.5.1 Viatris Company Information
- 4.5.2 Viatris Business Overview
- 4.5.3 Viatris Fexofenadine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Viatris Fexofenadine Hydrochloride Tablets Product Portfolio
- 4.5.5 Viatris Recent Developments
- 4.6 Teva Pharmaceuticals
- 4.6.1 Teva Pharmaceuticals Company Information
- 4.6.2 Teva Pharmaceuticals Business Overview
- 4.6.3 Teva Pharmaceuticals Fexofenadine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Teva Pharmaceuticals Fexofenadine Hydrochloride Tablets Product Portfolio
- 4.6.5 Teva Pharmaceuticals Recent Developments
- 4.7 Sun Pharmaceutical Industries Ltd.
- 4.7.1 Sun Pharmaceutical Industries Ltd. Company Information
- 4.7.2 Sun Pharmaceutical Industries Ltd. Business Overview
- 4.7.3 Sun Pharmaceutical Industries Ltd. Fexofenadine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sun Pharmaceutical Industries Ltd. Fexofenadine Hydrochloride Tablets Product Portfolio
- 4.7.5 Sun Pharmaceutical Industries Ltd. Recent Developments
- 4.8 Sun Pharmaceutical Industries
- 4.8.1 Sun Pharmaceutical Industries Company Information
- 4.8.2 Sun Pharmaceutical Industries Business Overview
- 4.8.3 Sun Pharmaceutical Industries Fexofenadine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sun Pharmaceutical Industries Fexofenadine Hydrochloride Tablets Product Portfolio
- 4.8.5 Sun Pharmaceutical Industries Recent Developments
- 4.9 Dr. Reddy's Laboratories
- 4.9.1 Dr. Reddy's Laboratories Company Information
- 4.9.2 Dr. Reddy's Laboratories Business Overview
- 4.9.3 Dr. Reddy's Laboratories Fexofenadine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Dr. Reddy's Laboratories Fexofenadine Hydrochloride Tablets Product Portfolio
- 4.9.5 Dr. Reddy's Laboratories Recent Developments
- 4.10 CSPC Pharmaceutical Group
- 4.10.1 CSPC Pharmaceutical Group Company Information
- 4.10.2 CSPC Pharmaceutical Group Business Overview
- 4.10.3 CSPC Pharmaceutical Group Fexofenadine Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 CSPC Pharmaceutical Group Fexofenadine Hydrochloride Tablets Product Portfolio
- 4.10.5 CSPC Pharmaceutical Group Recent Developments
5 Global Fexofenadine Hydrochloride Tablets Market Scenario by Region
- 5.1 Global Fexofenadine Hydrochloride Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Fexofenadine Hydrochloride Tablets Sales by Region: 2021-2032
- 5.2.1 Global Fexofenadine Hydrochloride Tablets Sales by Region: 2021-2026
- 5.2.2 Global Fexofenadine Hydrochloride Tablets Sales by Region: 2027-2032
- 5.3 Global Fexofenadine Hydrochloride Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Fexofenadine Hydrochloride Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Fexofenadine Hydrochloride Tablets Revenue by Region: 2027-2032
- 5.4 North America Fexofenadine Hydrochloride Tablets Market Facts & Figures by Country
- 5.4.1 North America Fexofenadine Hydrochloride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Fexofenadine Hydrochloride Tablets Sales by Country (2021-2032)
- 5.4.3 North America Fexofenadine Hydrochloride Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Fexofenadine Hydrochloride Tablets Market Facts & Figures by Country
- 5.5.1 Europe Fexofenadine Hydrochloride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Fexofenadine Hydrochloride Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Fexofenadine Hydrochloride Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Fexofenadine Hydrochloride Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Fexofenadine Hydrochloride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Fexofenadine Hydrochloride Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Fexofenadine Hydrochloride Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Fexofenadine Hydrochloride Tablets Market Facts & Figures by Country
- 5.7.1 South America Fexofenadine Hydrochloride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Fexofenadine Hydrochloride Tablets Sales by Country (2021-2032)
- 5.7.3 South America Fexofenadine Hydrochloride Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Fexofenadine Hydrochloride Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Fexofenadine Hydrochloride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Fexofenadine Hydrochloride Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Fexofenadine Hydrochloride Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Fexofenadine Hydrochloride Tablets Sales by Type (2021-2032)
- 6.1.1 Global Fexofenadine Hydrochloride Tablets Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Fexofenadine Hydrochloride Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Fexofenadine Hydrochloride Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Fexofenadine Hydrochloride Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Fexofenadine Hydrochloride Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Fexofenadine Hydrochloride Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Fexofenadine Hydrochloride Tablets Sales by Application (2021-2032)
- 7.1.1 Global Fexofenadine Hydrochloride Tablets Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Fexofenadine Hydrochloride Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Fexofenadine Hydrochloride Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Fexofenadine Hydrochloride Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Fexofenadine Hydrochloride Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Fexofenadine Hydrochloride Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Fexofenadine Hydrochloride Tablets Value Chain Analysis
- 8.1.1 Fexofenadine Hydrochloride Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Fexofenadine Hydrochloride Tablets Production Mode & Process
- 8.2 Fexofenadine Hydrochloride Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Fexofenadine Hydrochloride Tablets Distributors
- 8.2.3 Fexofenadine Hydrochloride Tablets Customers
9 Global Fexofenadine Hydrochloride Tablets Analyzing Market Dynamics
- 9.1 Fexofenadine Hydrochloride Tablets Industry Trends
- 9.2 Fexofenadine Hydrochloride Tablets Industry Drivers
- 9.3 Fexofenadine Hydrochloride Tablets Industry Opportunities and Challenges
- 9.4 Fexofenadine Hydrochloride Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst